Return to CAP Home

  Press Release

 

Published on September 11, 2012

Contact: Julie Monzo
Phone: 800-323-4040, ext. 7538
E-mail: jmonzo@cap.org

PITTSBURGH PATHOLOGIST RECEIVES COLLEGE OF AMERICAN PATHOLOGISTS LIFETIME ACHIEVEMENT AWARD

Northfield, IL. – The College of American Pathologists (CAP) awarded Jeffrey A. Kant, MD, PhD, FCAP, from Pittsburgh, Pa., the CAP Lifetime Achievement Award at a special ceremony held on September 10, 2012, in San Diego, Calif., at the College’s annual meeting, CAP ’12 — THE Pathologists’ Meeting™.

The CAP presents the Lifetime Achievement Award to its members who have made a broad and positive impact on patient care through the specialty of pathology. Dr. Kant was recognized for his significant contributions to the field of genetics and molecular diagnostics.

“I am deeply honored to receive the CAP Lifetime Achievement Award,” said Dr, Kant. “I look forward to many more years of service to pathologists, the medical profession and our patients.”

Currently, Dr. Kant is professor of pathology and human genetics and director of the Division of Molecular Diagnostics at the University of Pittsburgh Medical Center in Pennsylvania, where he directs fellowship programs in molecular genetic pathology and clinical molecular genetics. He is an elected Fellow of the American Association for the Advancement of Science and an appointed member of Centers for Disease Control and Prevention (CDC) Clinical Laboratory Improvement Advisory Committee (CLIAC).

Dr. Kant was raised in upstate New York where he graduated from Watertown High School. He received a bachelor’s degree in biology from Princeton University in New Jersey, followed by MD and PhD training at the University of Chicago in Illinois. He completed his residency training in AP/CP and research in tumor immunology at the University of Washington in Seattle, followed by an expert consultant role at the National Cancer Institute with emphases on hematopathology and molecular biology. Dr. Kant then moved to the University of Pennsylvania, where he directed the hematology laboratory and hematopathology training program and founded one of the nation’s first clinical molecular diagnostics laboratories in the mid 1980s.

Dr. Kant has devoted himself to translating discoveries in molecular pathogenesis into the clinical laboratory to benefit patients and physicians and to establish the field of clinical molecular diagnostics broadly. In addition to Dr. Kant’s interests in clinical molecular diagnostics, he lectures widely on economic and policy issues relating to molecular diagnostics. He was instrumental in the formation of the Association for Molecular Pathology (AMP) in the early 1990s, served as AMP’s first president and in numerous other capacities, and was the inaugural recipient of the AMP Leadership Award in 2005. Within the CAP, Dr. Kant is immediate past chair of the CAP/ACMG Biochemical and Molecular Genetics Resource Committee, vice chair of the Council on Scientific Affairs, and member of the CAP Economic Affairs and Personalized Health Care Committees, as well as the Laboratory-Developed Test and Next-Generation Sequencing workgroups.

The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society serving more than 18,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care.